Q3 2020 Holdings
Filed 2020-11-16 | 8 holdings | $366.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $366.1M | 9,699,925 | 99.9% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $118.8K | 3,504,624 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $75.3K | 2,444,311 | 0.0% |
| Checkmate Pharmaceuticals in | COM | 162818108 | $42.3K | 3,673,374 | 0.0% |
| Metacrine Inc | COM | 59101E103 | $31.2K | 3,059,123 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $15.1K | 501,584 | 0.0% |
| Precision Biosciences Inc | COM | 74019P108 | $8.0K | 1,298,191 | 0.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $1.2K | 199,075 | 0.0% |